Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

438 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion.
Shack S, Chen LC, Miller AC, Danesi R, Samid D. Shack S, et al. Among authors: danesi r. Int J Cancer. 1995 Sep 27;63(1):124-9. doi: 10.1002/ijc.2910630122. Int J Cancer. 1995. PMID: 7558439
Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.
Danesi R, Bernardini N, Agen C, Costa M, Zaccaro L, Pieracci D, Malvaldi G, Del Tacca M. Danesi R, et al. Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942. Cancer Chemother Pharmacol. 1992. PMID: 1472260
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Among authors: danesi r. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601
Effect of suramin on human prostate cancer cells in vitro.
La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Linehan WM, Myers CE. La Rocca RV, et al. Among authors: danesi r. J Urol. 1991 Feb;145(2):393-8. doi: 10.1016/s0022-5347(17)38351-9. J Urol. 1991. PMID: 1824865
Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation.
LaRocca RV, Cooper MR, Uhrich M, Danesi R, Walther MM, Linehan WM, Myers CE. LaRocca RV, et al. Among authors: danesi r. Urol Clin North Am. 1991 Feb;18(1):123-9. Urol Clin North Am. 1991. PMID: 1992566 Review.
A pilot study of suramin in the treatment of metastatic renal cell carcinoma.
La Rocca RV, Stein CA, Danesi R, Cooper MR, Uhrich M, Myers CE. La Rocca RV, et al. Among authors: danesi r. Cancer. 1991 Mar 15;67(6):1509-13. doi: 10.1002/1097-0142(19910315)67:6<1509::aid-cncr2820670608>3.0.co;2-f. Cancer. 1991. PMID: 2001538
Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.
Danesi R, Marchetti A, Bernardini N, La Rocca RV, Bevilacqua G, Del Tacca M. Danesi R, et al. Cancer Chemother Pharmacol. 1990;26(6):403-8. doi: 10.1007/BF02994089. Cancer Chemother Pharmacol. 1990. PMID: 2171795
Suramin, a novel antitumor compound.
La Rocca RV, Stein CA, Danesi R, Myers CE. La Rocca RV, et al. Among authors: danesi r. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):893-8. doi: 10.1016/0960-0760(90)90439-r. J Steroid Biochem Mol Biol. 1990. PMID: 2285603 Review.
Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats.
Danesi R, Bernardini N, Marchetti A, Bernardini M, Del Tacca M. Danesi R, et al. Cancer Chemother Pharmacol. 1990;25(5):326-32. doi: 10.1007/BF00686231. Cancer Chemother Pharmacol. 1990. PMID: 2306792
Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.
La Rocca RV, Stein CA, Danesi R, Jamis-Dow CA, Weiss GH, Myers CE. La Rocca RV, et al. Among authors: danesi r. J Clin Endocrinol Metab. 1990 Aug;71(2):497-504. doi: 10.1210/jcem-71-2-497. J Clin Endocrinol Metab. 1990. PMID: 2380344
438 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback